Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques

Rationale: Direct evidence for persistence of Mycobacterium tuberculosis (Mtb) during asymptomatic latent tuberculosis infection (LTBI) in humans is currently lacking. Moreover, although a 12-week regimen of once-weekly isoniazid and rifapentine (3HP) is currently recommended by the CDC as treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Respir Crit Care Med
Asıl Yazarlar: Foreman, Taylor W., Bucşan, Allison N., Mehra, Smriti, Peloquin, Charles, Doyle, Lara A., Russell-Lodrigue, Kasi, Gandhi, Neel R., Altman, John, Day, Cheryl L., Ernst, Joel D., Blumberg, Henry M., Rengarajan, Jyothi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Thoracic Society 2020
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049922/
https://ncbi.nlm.nih.gov/pubmed/31647877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201903-0646OC
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller